Nowadays, ABL2 is a theme that has captured the attention of people all over the world. Whether because of its relevance in today's society, its impact on people's lives, or its role in history, ABL2 has generated constant debate and sparked the interest of researchers, experts, and ordinary people alike. In this article, we will explore the topic of ABL2 in depth, analyzing its different facets, its implications in society and its relevance in today's world. Through an enriching and detailed approach, we will seek to better understand what ABL2 is, why it is important and how it influences our daily lives.
Tyrosine-protein kinase ABL2 also known as Abelson-related gene (Arg) is an enzyme that in humans is encoded by the ABL2gene.[5][6]
Function
ABL2 is a cytoplasmic tyrosine kinase which is closely related to but distinct from ABL1. The similarity of the proteins includes the tyrosine kinase domains and extends amino-terminal to include the SH2 and SH3 domains. ABL2 is expressed in both normal and tumor cells. The expression of ABL2 gene is higher in KRAS mutant non-small cell lung cancer.[7] The ABL2 gene product is expressed as two variants bearing different amino termini, both approximately 12-kb in length.[6]
Interactions
ABL2 has been shown to interact with three proteins: Abl gene,[8]catalase,[9] and SORBS2.[10] The protein Abl gene is also known as abelson murine leukemia viral oncogene homolog 1 and is a protein that is encoded by the human ABL1 gene.[11] Catalase is a common enzyme that catalyzes the decomposition of hydrogen peroxide to water and oxygen.[12] SORBS2 is also known as Sorbin and SH3 domain-containing protein 2 and is a protein encoded by the SORBS2 gene in humans.[6][10][13]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO, et al. (December 1986). "A novel human gene closely related to the abl proto-oncogene". Science. 234 (4783): 1545–1548. Bibcode:1986Sci...234.1545K. doi:10.1126/science.3787260. PMID3787260.
Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO, et al. (December 1986). "A novel human gene closely related to the abl proto-oncogene". Science. 234 (4783): 1545–1548. Bibcode:1986Sci...234.1545K. doi:10.1126/science.3787260. PMID3787260.
Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–174. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Wang B, Kruh GD (July 1996). "Subcellular localization of the Arg protein tyrosine kinase". Oncogene. 13 (1): 193–197. PMID8700546.
Wang B, Mysliwiec T, Feller SM, Knudsen B, Hanafusa H, Kruh GD (October 1996). "Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk". Oncogene. 13 (7): 1379–1385. PMID8875975.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–156. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.